74 related articles for article (PubMed ID: 22517119)
1. Inactivation of TRPM7 Kinase Targets AKT Signaling and Cyclooxygenase-2 Expression in Human CML Cells.
Hoeger B; Nadolni W; Hampe S; Hoelting K; Fraticelli M; Zaborsky N; Madlmayr A; Sperrer V; Fraticelli L; Addington L; Steinritz D; Chubanov V; Geisberger R; Greil R; Breit A; Boekhoff I; Gudermann T; Zierler S
Function (Oxf); 2023; 4(6):zqad053. PubMed ID: 37786778
[TBL] [Abstract][Full Text] [Related]
2. Arginine dependency is a therapeutically exploitable vulnerability in chronic myeloid leukaemic stem cells.
Rattigan KM; Zarou MM; Brabcova Z; Prasad B; Zerbst D; Sarnello D; Kalkman ER; Ianniciello A; Scott MT; Dunn K; Shokry E; Sumpton D; Copland M; Tardito S; Vande Voorde J; Mussai F; Cheng P; Helgason GV
EMBO Rep; 2023 Oct; 24(10):e56279. PubMed ID: 37489735
[TBL] [Abstract][Full Text] [Related]
3. A Simple Aptamer-Based Nanoconjugate Assay for Diagnosis of Chronic Myeloid Leukemia.
Mousavi SS; Ayatollahi H; Abnous K; Taghdisi SM; Sadeghian MH; Khatami F; Ahmadi A; Khoshbin Z
Appl Biochem Biotechnol; 2024 Jan; 196(1):145-159. PubMed ID: 37103734
[TBL] [Abstract][Full Text] [Related]
4. Proteomics for optimizing therapy in acute myeloid leukemia: venetoclax plus hypomethylating agents versus conventional chemotherapy.
de Camargo Magalhães ES; Hubner SE; Brown BD; Qiu Y; Kornblau SM
Leukemia; 2024 May; 38(5):1046-1056. PubMed ID: 38531950
[TBL] [Abstract][Full Text] [Related]
5. Overcoming BCR::ABL1 dependent and independent survival mechanisms in chronic myeloid leukaemia using a multi-kinase targeting approach.
Busch C; Mulholland T; Zagnoni M; Dalby M; Berry C; Wheadon H
Cell Commun Signal; 2023 Nov; 21(1):342. PubMed ID: 38031192
[TBL] [Abstract][Full Text] [Related]
6. Combined Inhibition of Bcl2 and Bcr-Abl1 Exercises Anti-Leukemia Activity but Does Not Eradicate the Primitive Leukemic Cells.
Massimino M; Vigneri P; Stella S; Tirrò E; Pennisi MS; Parrinello LN; Vetro C; Manzella L; Stagno F; Di Raimondo F
J Clin Med; 2021 Nov; 10(23):. PubMed ID: 34884309
[TBL] [Abstract][Full Text] [Related]
7. Atypical activation of signaling downstream of inactivated Bcr-Abl mediates chemoresistance in chronic myeloid leukemia.
Narasimhan M; Khamkar V; Tilwani S; Dalal SN; Shetty D; Subramanian PG; Gupta S; Govekar R
J Cell Commun Signal; 2022 Jun; 16(2):207-222. PubMed ID: 34596797
[TBL] [Abstract][Full Text] [Related]
8. TRIM24 promotes stemness and invasiveness of glioblastoma cells via activating Sox2 expression.
Zhang LH; Yin YH; Chen HZ; Feng SY; Liu JL; Chen L; Fu WL; Sun GC; Yu XG; Xu DG
Neuro Oncol; 2020 Dec; 22(12):1797-1808. PubMed ID: 32492707
[TBL] [Abstract][Full Text] [Related]
9. Venetoclax and BCR-ABL Tyrosine Kinase Inhibitor Combinations: Outcome in Patients with Philadelphia Chromosome-Positive Advanced Myeloid Leukemias.
Maiti A; Franquiz MJ; Ravandi F; Cortes JE; Jabbour EJ; Sasaki K; Marx K; Daver NG; Kadia TM; Konopleva MY; Masarova L; Borthakur G; DiNardo CD; Naqvi K; Pierce S; Kantarjian HM; Short NJ
Acta Haematol; 2020; 143(6):567-573. PubMed ID: 32289808
[TBL] [Abstract][Full Text] [Related]
10. Differential proteomic profile of leukemic CD34+ progenitor cells from chronic myeloid leukemia patients.
Ricciardi MR; Salvestrini V; Licchetta R; Mirabilii S; Forcato M; Gugliotta G; Salati S; Castagnetti F; Rosti G; Breccia M; Alimena G; Manfredini R; Bicciato S; Lemoli RM; Tafuri A
Oncotarget; 2018 Apr; 9(31):21758-21769. PubMed ID: 29774100
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis-Inducing Factor (AIF) in Physiology and Disease: The Tale of a Repented Natural Born Killer.
Bano D; Prehn JHM
EBioMedicine; 2018 Apr; 30():29-37. PubMed ID: 29605508
[TBL] [Abstract][Full Text] [Related]
12. Combined targeting of BCL-2 and BCR-ABL tyrosine kinase eradicates chronic myeloid leukemia stem cells.
Carter BZ; Mak PY; Mu H; Zhou H; Mak DH; Schober W; Leverson JD; Zhang B; Bhatia R; Huang X; Cortes J; Kantarjian H; Konopleva M; Andreeff M
Sci Transl Med; 2016 Sep; 8(355):355ra117. PubMed ID: 27605552
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profile of circulating CD34(+) cells and granulocytes in chronic myeloid leukemia.
Čokić VP; Mojsilović S; Jauković A; Kraguljac-Kurtović N; Mojsilović S; Šefer D; Mitrović Ajtić O; Milošević V; Bogdanović A; Đikić D; Milenković P; Puri RK
Blood Cells Mol Dis; 2015 Dec; 55(4):373-81. PubMed ID: 26460262
[TBL] [Abstract][Full Text] [Related]
14. Inhibitor of Apoptosis (IAP) proteins in hematological malignancies: molecular mechanisms and therapeutic opportunities.
Fulda S
Leukemia; 2014 Jul; 28(7):1414-22. PubMed ID: 24487414
[TBL] [Abstract][Full Text] [Related]
15. TRIM24 promotes glioma progression and enhances chemoresistance through activation of the PI3K/Akt signaling pathway.
Zhang LH; Yin AA; Cheng JX; Huang HY; Li XM; Zhang YQ; Han N; Zhang X
Oncogene; 2015 Jan; 34(5):600-10. PubMed ID: 24469053
[TBL] [Abstract][Full Text] [Related]
16. Genetic events other than BCR-ABL1.
Neviani P
Curr Hematol Malig Rep; 2014 Mar; 9(1):24-32. PubMed ID: 24407376
[TBL] [Abstract][Full Text] [Related]
17. Alterations of Gab2 signalling complexes in imatinib and dasatinib treated chronic myeloid leukaemia cells.
Halbach S; Rigbolt KT; Wöhrle FU; Diedrich B; Gretzmeier C; Brummer T; Dengjel J
Cell Commun Signal; 2013 Apr; 11(1):30. PubMed ID: 23607741
[TBL] [Abstract][Full Text] [Related]
18. Robust microarray production of freshly expressed proteins in a human milieu.
Festa F; Rollins SM; Vattem K; Hathaway M; Lorenz P; Mendoza EA; Yu X; Qiu J; Kilmer G; Jensen P; Webb B; Ryan ET; LaBaer J
Proteomics Clin Appl; 2013 Jun; 7(5-6):372-7. PubMed ID: 23027544
[TBL] [Abstract][Full Text] [Related]
19. Reverse phase protein array profiling reveals distinct proteomic signatures associated with chronic myeloid leukemia progression and with chronic phase in the CD34-positive compartment.
Quintás-Cardama A; Qiu YH; Post SM; Zhang Y; Creighton CJ; Cortes J; Kornblau SM
Cancer; 2012 Nov; 118(21):5283-92. PubMed ID: 22517119
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
